Showing 241-260 of 7110 for: Cochrane Systematic Reviews Back
- Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities
Cochrane Systematic Reviews, 13-Apr-2010
Attention-deficit hyperactivity disorder (ADHD) is increasingly recognised as occurring in people with intellectual disability (ID), although treatment of ADHD in this population has not been tested widely. Amfetamine has been used to treat ADHD in people
- Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer
Cochrane Systematic Reviews, 6-Aug-2009
Radioactive iodine treatment for differentiated thyroid cancer possibly results in xerostomia. Amifostine has been used to prevent the effects of irradiation to salivary glands. To date, the effects of amifostine on salivary glands in radioactive iodine t
- Amino acids for amyotrophic lateral sclerosis / motor neuron disease
Cochrane Systematic Reviews, 3-Nov-2008
Amyotrophic lateral sclerosis, also known as motor neuron disease, is a progressive neuromuscular disease that causes disability and eventual death. Various amino acid preparations, the three branched-chain amino acids (L-leucine, L-valine and L-isoleucin
- Aminoadamantanes for chronic hepatitis C
Cochrane Systematic Reviews, 2-May-2014
Around 3% of the world's population (approximately 160 million people) are chronically infected with hepatitis C virus. The proportion of infected people who develop clinical symptoms varies between 5% and 40%. Combination therapy with pegylated interfero
- Aminoadamantanes versus other antiviral drugs for chronic hepatitis C
Cochrane Systematic Reviews, 17-Jun-2014
Hepatitis C virus infection affects around 3% of the world population or approximately 160 million people. A variable proportion (5% to 40%) of the infected people develop clinical symptoms. Hence, hepatitis C virus is a leading cause of liver-related mor
- Aminophylline for bradyasystolic cardiac arrest in adults
Cochrane Systematic Reviews, 23-Nov-2015
In cardiac ischaemia, the accumulation of adenosine may lead to or exacerbate bradyasystole and diminish the effectiveness of catecholamines administered during resuscitation. Aminophylline is a competitive adenosine antagonist. Case studies suggest that
- Aminopyridines for symptomatic treatment in multiple sclerosis
Cochrane Systematic Reviews, 17-Sep-2008
The potassium channel blockers 4-aminopyridine (AP) and 3,4-diaminopyridine (DAP) increase nerve conduction in demyelinated nerve fibers, and have been proposed as a symptomatic therapy for people with multiple sclerosis (MS).
- Aminosalicylates for induction of remission or response in Crohn's disease
Cochrane Systematic Reviews, 20-Jun-2011
Controlled clinical trials investigating the efficacy of aminosalicylates for the treatment of mildly to moderately active Crohn's disease have yielded conflicting results. A systematic review was conducted to critically examine current available data on
- Aminosteroids for acute traumatic brain injury
Cochrane Systematic Reviews, 10-May-2010
Traumatic brain injury is a leading cause of premature death and disability. Post-traumatic membrane lipid peroxidation has been proposed as one mechanism leading to secondary brain damage following head injury. Aminosteroids have been shown to inhibit li
- Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death
Cochrane Systematic Reviews, 8-Dec-2015
Sudden cardiac death (SCD) is one of the main causes of cardiac death. There are two main strategies to prevent it: managing cardiovascular risk factors and reducing the risk of ventricular arrhythmias. Implantable cardiac defibrillators (ICDs) constitute
- Amisulpride for schizophrenia
Cochrane Systematic Reviews, 12-Dec-2012
The treatment of schizophrenia with old, 'typical' antipsychotic drugs such as haloperidol can be problematic, because many people treated with these drugs will suffer from movement disorders. Amisulpride is said to be an "atypical" antipsychotic which in
- Amisulpride versus other atypical antipsychotics for schizophrenia
Cochrane Systematic Reviews, 15-Jan-2013
In many countries of the industrialised world second generation (atypical) antipsychotics have become first line drug treatments for people with schizophrenia. The question as to whether, and if so how much, the effects of the various second generation an
- Amitriptyline for depression
Cochrane Systematic Reviews, 31-Oct-2008
For many years amitriptyline has been considered one of the reference compounds for the pharmacological treatment of depression. However, new tricyclic drugs, heterocyclic compounds and selective serotonin reuptake inhibitors have been introduced on the m
- Amitriptyline for fibromyalgia in adults
Cochrane Systematic Reviews, 31-Jul-2015
This is an updated version of the original Cochrane review published in Issue 12, 2012. That review considered both fibromyalgia and neuropathic pain, but the efficacy of amitriptyline for neuropathic pain is now dealt with in a separate review.
- Amitriptyline for neuropathic pain in adults
Cochrane Systematic Reviews, 7-Jul-2015
This is an updated version of the original Cochrane review published in Issue 12, 2012. That review considered both fibromyalgia and neuropathic pain, but the effects of amitriptyline for fibromyalgia are now dealt with in a separate review.
- Amitriptyline versus placebo for major depressive disorder
Cochrane Systematic Reviews, 12-Nov-2012
Amitriptyline is a tricyclic antidepressant that was synthesised in 1960 and introduced as early as 1961 in the USA, but is still regularly used. It has also been frequently used as an active comparator in trials on newer antidepressants and can therefore
- Amniocentesis and chorionic villus sampling for prenatal diagnosis
Cochrane Systematic Reviews, 5-Jan-2009
A major disadvantage of second trimester amniocentesis is that the results are available relatively late in pregnancy (after 16 weeks' gestation). Chorionic villus sampling (CVS) and early amniocentesis can be done in the first trimester of pregnancy and
- Amnioinfusion for meconium-stained liquor in labour
Cochrane Systematic Reviews, 20-Jan-2014
Amnioinfusion is thought to dilute meconium present in the amniotic fluid and so reduce the risk of meconium aspiration.
- Amnioinfusion for potential or suspected umbilical cord compression in labour
Cochrane Systematic Reviews, 1-Dec-2011
Amnioinfusion aims to prevent or relieve umbilical cord compression during labour by infusing a solution into the uterine cavity.
- Amnioinfusion for third trimester preterm premature rupture of membranes
Cochrane Systematic Reviews, 28-Mar-2014
Preterm premature rupture of membranes (PPROM) is a leading cause of perinatal morbidity and mortality. Amnioinfusion aims to restore amniotic fluid volume by infusing a solution into the uterine cavity.
